Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingEqual
- # of holdings43
What's inside?
Sectors
- Health Technology56.93%
- Health Services20.58%
- Technology Services18.56%
- Commercial Services2.08%
- Finance1.86%
Holdings
All holdings as of November 25, 2024
Hims & Hers Health, Inc. (HIMS) | 3.79% | $5.32B | 77.13% | 67.33% | 3.29 |
Guardant Health, Inc. (GH) | 3.40% | $4.03B | 33.87% | 61.10% | 4.57 |
GRAIL, Inc. (GRAL) | 2.90% | $594.06M | 38.27% | -77.60% | -2.76 |
PROCEPT BioRobotics Corp. (PRCT) | 2.87% | $5.09B | 66.29% | 60.96% | 20.27 |
Teladoc Health, Inc. (TDOC) | 2.85% | $1.83B | -2.99% | 57.95% | 0.74 |
Cytek Biosciences, Inc. (CTKB) | 2.82% | $843.71M | 7.29% | 56.32% | 2.44 |
iRhythm Technologies, Inc. (IRTC) | 2.80% | $2.32B | 18.41% | 68.78% | 4.53 |
Masimo Corp. (MASI) | 2.73% | $9.26B | 5.37% | 52.16% | 3.88 |
Schrödinger, Inc. (SDGR) | 2.72% | $1.33B | -17.10% | 50.24% | 5.55 |
Natera, Inc. (NTRA) | 2.70% | $22.08B | 63.90% | 61.79% | 9.97 |
Veracyte, Inc. (VCYT) | 2.67% | $3.07B | 28.58% | 66.19% | 5.68 |
NeoGenomics, Inc. (NEO) | 2.60% | $2.10B | 10.44% | 42.56% | 3.25 |
Tempus AI, Inc. (TEM) | 2.58% | $9.74B | N/A | 56.80% | 29.25 |
Globus Medical, Inc. (GMED) | 2.55% | $9.64B | 63.10% | 51.96% | 3.92 |
Insulet Corp. (PODD) | 2.47% | $18.44B | 25.70% | 70.12% | 8.93 |
Waystar Holding Corp. (WAY) | 2.45% | $5.33B | 21.72% | 41.39% | 6.66 |
DexCom, Inc. (DXCM) | 2.44% | $28.45B | 1.97% | 59.73% | 6.98 |
Intuitive Surgical, Inc. (ISRG) | 2.38% | $195.14B | 16.88% | 67.41% | 22.12 |
Doximity, Inc. (DOCS) | 2.37% | $6.18B | 20.44% | 90.01% | 15.36 |
Veeva Systems, Inc. (VEEV) | 2.37% | $35.07B | 14.56% | 74.80% | 10.40 |
Health Catalyst, Inc. (HCAT) | 2.37% | $494.69M | 3.50% | 31.77% | 1.55 |
Lifestance Health Group, Inc. (LFST) | 2.35% | $2.83B | 18.95% | 27.28% | 2.53 |
Pacific Biosciences of California, Inc. (PACB) | 2.31% | $492.95M | -28.23% | 7.39% | 5.27 |
Twist Bioscience Corp. (TWST) | 2.29% | $2.51B | 27.69% | 42.61% | 7.76 |
ResMed, Inc. (RMD) | 2.28% | $35.79B | 11.08% | 57.64% | 7.58 |
Definitive Healthcare Corp. (DH) | 2.20% | $504.83M | -4.02% | 63.09% | 2.58 |
Illumina, Inc. (ILMN) | 2.18% | $22.23B | -3.49% | 68.98% | 5.14 |
Adaptive Biotechnologies Corp. (ADPT) | 2.17% | $692.15M | 22.46% | 58.81% | 4.15 |
Castle Biosciences, Inc. (CSTL) | 2.15% | $834.90M | 39.50% | 78.57% | 1.88 |
Align Technology, Inc. (ALGN) | 2.14% | $16.86B | 1.84% | 70.10% | 4.57 |
Hologic, Inc. (HOLX) | 2.13% | $18.34B | -0.00% | 55.52% | 4.81 |
Progyny, Inc. (PGNY) | 2.08% | $1.31B | 2.04% | 20.67% | 1.19 |
Inspire Medical Systems, Inc. (INSP) | 2.00% | $5.66B | 32.54% | 84.06% | 8.05 |
IQVIA Holdings, Inc. (IQV) | 1.91% | $36.63B | 4.06% | 28.18% | 3.63 |
Fulgent Genetics, Inc. (FLGT) | 1.89% | $546.59M | -15.28% | 34.54% | 1.64 |
Clover Health Investments Corp. (CLOV) | 1.86% | $1.39B | -31.34% | N/A | 0.90 |
Oscar Health, Inc. (OSCR) | 1.80% | $3.38B | 68.30% | N/A | 0.66 |
EXACT Sciences Corp. (EXAS) | 1.74% | $9.79B | 12.78% | 68.88% | 5.33 |
CareDx, Inc. (CDNA) | 1.69% | $1.24B | 23.35% | 65.97% | 4.61 |
10X Genomics, Inc. (TXG) | 1.66% | $1.53B | -1.30% | 69.50% | 3.83 |
Tandem Diabetes Care, Inc. (TNDM) | 1.57% | $2.02B | 31.43% | 51.09% | 3.26 |
GoodRx Holdings, Inc. (GDRX) | 1.50% | $510.94M | 8.50% | 85.04% | 3.56 |
Myriad Genetics, Inc. (MYGN) | 1.29% | $1.41B | 11.15% | 65.31% | 3.08 |